Clinical Trials

Condition or Disease

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

1 studies in Hepatic veno-occlusive disease (VOD)

  1. Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study Jacksonville, FL Scottsdale and Phoenix, AZ Rochester, MN View Summary

    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

    Location:

    Jacksonville, FL Scottsdale and Phoenix, AZ Rochester, MN

    Trial status:

    Open for Enrollment

    Why is this study being done?

    Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism (also known as compassionate use, or single patient named use). This protocol is the only mechanism by which Defibrotide can be made available to patients in the U.S.

    NCT ID:

    NCT00628498

    IRB Number:

    08-002241

    Who can I contact for additional information about this study?

    - Mayo Clinic Cancer Center - Phone: 507-538-7623 - Research Volunteer Program - Phone: 1-800-664-4542 (toll-free) Email: clinicaltrials@mayo.edu - International Research - Phone: 507-284-8884 Email: intl.mcr@mayo.edu

Contact us

Clinical studies questions

Cancer-related clinical studies questions

International patient clinical studies questions